Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

11 results
Display

Massive Pleural Effusion as the First Manifestation of Malignant Melanoma Metastasis

Kim HG, Ryu JS, Kwak SM, Lee HL, Kim L, Cho JH

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):289-291.
  • doi: 10.4046/trd.2004.57.3.289
Malignant melanoma develops from melanocytes and frequently metastases to other organs. Common metastatic sites are other skin, lymph nodes, lung, liver, brain and bone in decreasing order of frequency. Malignant...
A Case of Central Diabetes Insipidus in Patient with Non-small Cell Lung Cancer

Hwang EM, Oh YK, Kim KJ, Kim YH, Yoon HK, Song JS

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):284-288.
  • doi: 10.4046/trd.2004.57.3.284
Central diabetes insipidus (DI) is a disease caused by insufficient release of antidiuretic hormone. Central DI with lung cancer is very rare. Most of them are caused by the pituitary...
A Case of Primary Leiomyosarcoma with Prominent Osteoclast-like Giant Cell of Lung with Cardiac Invasion

Song KR, Cho Y, Sin SK, Jeon HS, Hyun WJ, Lee YD, Han MS, Rho JY, Kim KH

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):278-283.
  • doi: 10.4046/trd.2004.57.3.278
The incidence of a pulmonary leiomyosarcoma as a primary lung tumor is quite rare. We report a case of primary leiomyosarcoma with a cardiac invasion in a 76 year old...
A Case of Methotrexate Induced Pneumonitis in a Patient with Rheumatoid Arthritis

Park CS, Lee SH, Shim KH, Kim WU, Lee SY, Kim SC, Kim KH, Moon HS, Song JS, Park SH

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):273-277.
  • doi: 10.4046/trd.2004.57.3.273
Methotrexate is commonly used in rheumatoid arthritis as an anti-inflammatory agent, but treatment with methotrexate can lead to severe side effects, especially pulmonary complication. Interstitial pneumonitis is one of the...
Association between RASSF1A Methylation and Clinicopathological Factors in Patients with Squamous Cell Carcinoma of Lung

Choi N, Lee HS, Song IS, Lim YS, Son DS, Lim DS, Choi YS, Kim J, Kim H

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):265-272.
  • doi: 10.4046/trd.2004.57.3.265
BACKGROUND: RASSF1A, which is one of tumor suppressor genes, is frequently inactivated by hypermethylation of the promoter region in a variety of human cancers, including lung cancer. This study was...
Concurrent Docetaxel/Cisplatin and Thoracic Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer

Jang TW, Park JP, Kim HK, Ok CH, Jeung TS, Jung MH

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):257-264.
  • doi: 10.4046/trd.2004.57.3.257
BACKGROUND: There are many combinations of treatment for locally advanced non-small cell lung cancer (NSCLC). Recent studies have showed the efficacy of concurrent chemoradiotherapy (CCRT) in NSCLC. At present, however,...
Neutrophil Apoptosis and H2O2 Release by LPS in Diabetics

Seo KH, Na JO, Moon SH, Uh ST, Kim YH, Park CS

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):250-256.
  • doi: 10.4046/trd.2004.57.3.250
BACKGROUND: Bacterial infections in diabetic patients are an important cause of increased morbidity and mortality. It has been reported that bacterial infections in diabetics showed more impaired PMN functions such...
Usefulness of Bronchoscopy for the Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease

Jeon K, Koh WJ, Kwon OJ, Kang EH, Suh GY, Chung MP, Kim H, Kim TS, Lee KS, Lee NY, Han J

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):242-249.
  • doi: 10.4046/trd.2004.57.3.242
BACKGROUND: Because of the low sensitivity of sputum smear and culture, diagnosis of nontuberculous mycobac?terium (NTM) pulmonary disease, especially in patients with bronchiectasis, is often difficult. We investigated the usefulness...
Treatment of Mycobacterium avium Complex (MAC) Pulmonary Disease

Koh WJ, Kwon OJ, Kang EH, Suh GY, Chung MP, Kim H, Chung MJ, Kim TS, Lee KS, Lee NY, Park YK, Bai GH

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):234-241.
  • doi: 10.4046/trd.2004.57.3.234
BACKGROUND: There has been a gradual increase in the number of newly diagnosed cases of Mycobacterium avium complex (MAC) pulmonary disease. However, the optimal therapeutic regimen for the disease has...
The Adjuvant Effect of Subcutaneous Interferon-gamma in the Treatment of Refractory Multidrug-resistant Pulmonary Tuberculosis

Kim EK, Shim TS, Lee JY, Oh YM, Lim CM, Lee SD, Koh Y, Kim DS, Kim WD, Kim WS

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):226-233.
  • doi: 10.4046/trd.2004.57.3.226
BACKGROUND: Interferon-gamma (IFN-gamma) is a critical cytokine in the defense against a Mycobacterium tuberculosis infection. Even though IFN-gamma has occasionally been used in the treatment of refractory multidrug-resistant tuberculosis (MDR-TB)...
Bronchial Provocation Test

Yoon HJ

  • Tuberc Respir Dis.
  • 2004 Sep;57(3):221-225.
  • doi: 10.4046/trd.2004.57.3.221
No abstract available.

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr